Telmisartan Plus Tablets 40/12.5 mg

Adult dose

In patients where blood pressure is not adequately controlled by monotherapy with telmisartan, this medication should be taken once daily with water, with or without food. Before switching to this fixed-dose combination, it is recommended to adjust the dosage of each active ingredient individually for each patient. If clinically appropriate, direct switching from monotherapy to this medication may be considered. - Telmisartan / Hydrochlorothiazide Combination 40/

Child dose

Safety and efficacy in pediatric patients under 18 years have not been established, so it should not be administered.

This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women. Patients who are allergic to any of the ingredients in this medication or those with certain liver or kidney diseases should not take this medication. Elderly patients, those with hyperkalemia, or patients with liver disorders should consult a physician before use and exercise caution. This medication lowers blood pressure, so it is important to be cautious of symptoms such as dizziness or fainting due to excessively low blood pressure. The hydrochlorothiazide component may cause electrolyte imbalances, so regular monitoring of serum potassium, sodium, etc., is necessary. Care should be taken to avoid excessive sunlight exposure while on this medication, and any skin rash or unusual reactions should be reported to a physician immediately. Since there may be interactions with other medications, it's crucial to inform your doctor or pharmacist of any current medications you are taking and seek advice. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, necessitating an immediate visit to a medical institution. The safety and efficacy of this medication have not been established in children, so use is not recommended, and for the elderly, blood pressure-lowering effects should be carefully monitored during administration. This medication should be kept out of the reach of children, and it is advisable to take it immediately after opening the packaging.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances,

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, paresthesia, visual disturbances, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, respiratory distress, respiratory pain, pulmonary inflammation, pulmonary edema, diarrhea, dry mouth, bloating, abdominal pain, constipation, dyspepsia, vomiting, liver function abnormality/liver impairment, erythema, pruritus, rash, hyperhidrosis,

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C to preserve its effectiveness.

Appearance

White or almost white, round, biconvex tablets.

Package unit

30 tablets (10 tablets/PTP x 3), 100 tablets/bottle